nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—CYP3A4—Bexarotene—hematologic cancer	0.0453	0.0829	CbGbCtD
Dofetilide—CYP3A4—Lomustine—hematologic cancer	0.0421	0.0771	CbGbCtD
Dofetilide—CYP3A4—Busulfan—hematologic cancer	0.0421	0.0771	CbGbCtD
Dofetilide—CYP3A4—Thiotepa—hematologic cancer	0.0375	0.0687	CbGbCtD
Dofetilide—CYP3A4—Methoxsalen—hematologic cancer	0.0292	0.0534	CbGbCtD
Dofetilide—CYP3A4—Bortezomib—hematologic cancer	0.0278	0.0508	CbGbCtD
Dofetilide—CYP3A4—Daunorubicin—hematologic cancer	0.0266	0.0486	CbGbCtD
Dofetilide—CYP3A4—Cytarabine—hematologic cancer	0.0234	0.0429	CbGbCtD
Dofetilide—CYP3A4—Teniposide—hematologic cancer	0.0231	0.0422	CbGbCtD
Dofetilide—CYP3A4—Ifosfamide—hematologic cancer	0.0213	0.039	CbGbCtD
Dofetilide—CYP3A4—Imatinib—hematologic cancer	0.0203	0.0372	CbGbCtD
Dofetilide—CYP3A4—Ruxolitinib—hematologic cancer	0.0192	0.0351	CbGbCtD
Dofetilide—CYP3A4—Nilotinib—hematologic cancer	0.0185	0.0338	CbGbCtD
Dofetilide—CYP3A4—Vinorelbine—hematologic cancer	0.0183	0.0335	CbGbCtD
Dofetilide—CYP3A4—Triamcinolone—hematologic cancer	0.0168	0.0307	CbGbCtD
Dofetilide—CYP3A4—Dasatinib—hematologic cancer	0.0163	0.0299	CbGbCtD
Dofetilide—CYP3A4—Mitoxantrone—hematologic cancer	0.0161	0.0295	CbGbCtD
Dofetilide—CYP3A4—Betamethasone—hematologic cancer	0.0144	0.0263	CbGbCtD
Dofetilide—CYP3A4—Prednisolone—hematologic cancer	0.0142	0.026	CbGbCtD
Dofetilide—CYP3A4—Prednisone—hematologic cancer	0.0134	0.0245	CbGbCtD
Dofetilide—CYP3A4—Irinotecan—hematologic cancer	0.0127	0.0233	CbGbCtD
Dofetilide—CYP3A4—Vinblastine—hematologic cancer	0.0113	0.0207	CbGbCtD
Dofetilide—CYP3A4—Vincristine—hematologic cancer	0.0111	0.0203	CbGbCtD
Dofetilide—CYP3A4—Etoposide—hematologic cancer	0.0102	0.0186	CbGbCtD
Dofetilide—CYP3A4—Dexamethasone—hematologic cancer	0.00837	0.0153	CbGbCtD
Dofetilide—CYP3A4—Doxorubicin—hematologic cancer	0.00694	0.0127	CbGbCtD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—LMO2—hematologic cancer	0.00403	0.0626	CbGpPWpGaD
Dofetilide—KCNJ12—Activation of GABAB receptors—ADCY7—hematologic cancer	0.00312	0.0484	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—LYL1—hematologic cancer	0.00305	0.0474	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CBFA2T3—hematologic cancer	0.00305	0.0474	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—GYPA—hematologic cancer	0.00259	0.0403	CbGpPWpGaD
Dofetilide—KCNJ12—GABA receptor activation—ADCY7—hematologic cancer	0.00239	0.0371	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—SPI1—hematologic cancer	0.00175	0.0272	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IKZF1—hematologic cancer	0.00175	0.0272	CbGpPWpGaD
Dofetilide—KCNJ12—lung—hematologic cancer	0.00173	0.322	CbGeAlD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—GATA2—hematologic cancer	0.00154	0.024	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—GATA1—hematologic cancer	0.00133	0.0206	CbGpPWpGaD
Dofetilide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—hematologic cancer	0.00126	0.0196	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—RUNX1—hematologic cancer	0.00121	0.0189	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY7—hematologic cancer	0.0011	0.0171	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—hematologic cancer	0.00109	0.017	CbGpPWpGaD
Dofetilide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—hematologic cancer	0.00103	0.016	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.00103	0.016	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—hematologic cancer	0.000977	0.0152	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CSF1—hematologic cancer	0.000971	0.0151	CbGpPWpGaD
Dofetilide—KCNK2—testis—hematologic cancer	0.000931	0.174	CbGeAlD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000901	0.014	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—MYB—hematologic cancer	0.000886	0.0138	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000826	0.0128	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000735	0.0114	CbGpPWpGaD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.000731	0.0114	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.000712	0.0111	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—SLC22A1—hematologic cancer	0.00069	0.0107	CbGpPWpGaD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.000687	0.0107	CbGpPWpGaD
Dofetilide—KCNK2—lymph node—hematologic cancer	0.000675	0.126	CbGeAlD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—EPO—hematologic cancer	0.000672	0.0104	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—ADCY7—hematologic cancer	0.000633	0.00983	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CXCR4—hematologic cancer	0.000626	0.00972	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	0.000618	0.0096	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL3—hematologic cancer	0.000603	0.00938	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—CAMK2D—hematologic cancer	0.000563	0.00875	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.000563	0.00875	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—GATA2—hematologic cancer	0.000519	0.00807	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—KITLG—hematologic cancer	0.000516	0.00802	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—STAT5A—hematologic cancer	0.000504	0.00784	CbGpPWpGaD
Dofetilide—KCNH2—hematopoietic system—hematologic cancer	0.000474	0.0884	CbGeAlD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CSF2—hematologic cancer	0.000469	0.00729	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000464	0.00722	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—RET—hematologic cancer	0.000459	0.00713	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000458	0.00711	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000452	0.00702	CbGpPWpGaD
Dofetilide—CYP3A4—Irinotecan Pathway—UGT1A1—hematologic cancer	0.000439	0.00683	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—SLC22A1—hematologic cancer	0.000438	0.00681	CbGpPWpGaD
Dofetilide—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hematologic cancer	0.00043	0.00669	CbGpPWpGaD
Dofetilide—Rosiglitazone—ALB—hematologic cancer	0.000413	0.371	CrCbGaD
Dofetilide—KCNK2—Neuronal System—ADCY7—hematologic cancer	0.000402	0.00624	CbGpPWpGaD
Dofetilide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—hematologic cancer	0.000402	0.00624	CbGpPWpGaD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.0004	0.00621	CbGpPWpGaD
Dofetilide—CYP3A4—Irinotecan Pathway—ABCG2—hematologic cancer	0.000381	0.00592	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000379	0.00588	CbGpPWpGaD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	0.000372	0.00578	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—hematologic cancer	0.00036	0.0056	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—UGT1A1—hematologic cancer	0.000359	0.00558	CbGpPWpGaD
Dofetilide—Dronedarone—ALB—hematologic cancer	0.000359	0.322	CrCbGaD
Dofetilide—KCNK2—Neuronal System—CAMK2D—hematologic cancer	0.000357	0.00556	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—PRKCG—hematologic cancer	0.000356	0.00553	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000344	0.00535	CbGpPWpGaD
Dofetilide—Dronedarone—ABCB1—hematologic cancer	0.000343	0.308	CrCbGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.00034	0.00528	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—FOS—hematologic cancer	0.000336	0.00522	CbGpPWpGaD
Dofetilide—CYP3A4—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	0.000323	0.00503	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	0.000323	0.00502	CbGpPWpGaD
Dofetilide—KCNH2—blood—hematologic cancer	0.000314	0.0586	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	0.000313	0.00486	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	0.00031	0.00482	CbGpPWpGaD
Dofetilide—KCNH2—bone marrow—hematologic cancer	0.000304	0.0567	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—MYB—hematologic cancer	0.000298	0.00464	CbGpPWpGaD
Dofetilide—CYP3A4—hematopoietic system—hematologic cancer	0.000294	0.0548	CbGeAlD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000291	0.00452	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000285	0.00442	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—CREB1—hematologic cancer	0.000264	0.0041	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—BRAF—hematologic cancer	0.00026	0.00404	CbGpPWpGaD
Dofetilide—KCNH2—testis—hematologic cancer	0.00026	0.0485	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL13—hematologic cancer	0.000255	0.00397	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—hematologic cancer	0.000249	0.00387	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	0.000246	0.00383	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000241	0.00375	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—GATA3—hematologic cancer	0.00023	0.00358	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.00023	0.00357	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000227	0.00352	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—PRKCG—hematologic cancer	0.000226	0.00351	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—MDM2—hematologic cancer	0.000218	0.00339	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	0.000208	0.00323	CbGpPWpGaD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	0.000203	0.00316	CbGpPWpGaD
Dofetilide—CYP3A4—blood—hematologic cancer	0.000195	0.0363	CbGeAlD
Dofetilide—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	0.000189	0.00293	CbGpPWpGaD
Dofetilide—KCNH2—lymph node—hematologic cancer	0.000188	0.0351	CbGeAlD
Dofetilide—KCNH2—Neuronal System—SLC22A1—hematologic cancer	0.000186	0.00289	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—AR—hematologic cancer	0.000183	0.00284	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000177	0.00275	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—ADCY7—hematologic cancer	0.00017	0.00264	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—CREB1—hematologic cancer	0.000167	0.0026	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—BRAF—hematologic cancer	0.000165	0.00257	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.000161	0.0025	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.00016	0.00248	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—HRAS—hematologic cancer	0.000156	0.00243	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CAMK2D—hematologic cancer	0.000151	0.00235	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.000148	0.0023	CbGpPWpGaD
Dofetilide—Asthenia—Carmustine—hematologic cancer	0.000146	0.000383	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000146	0.00227	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—hematologic cancer	0.000146	0.00226	CbGpPWpGaD
Dofetilide—Angioedema—Dexamethasone—hematologic cancer	0.000145	0.00038	CcSEcCtD
Dofetilide—Angioedema—Betamethasone—hematologic cancer	0.000145	0.00038	CcSEcCtD
Dofetilide—Diarrhoea—Thalidomide—hematologic cancer	0.000145	0.00038	CcSEcCtD
Dofetilide—Dizziness—Thiotepa—hematologic cancer	0.000145	0.00038	CcSEcCtD
Dofetilide—Asthenia—Alitretinoin—hematologic cancer	0.000145	0.000379	CcSEcCtD
Dofetilide—Rash—Vinorelbine—hematologic cancer	0.000145	0.000379	CcSEcCtD
Dofetilide—Dermatitis—Vinorelbine—hematologic cancer	0.000145	0.000379	CcSEcCtD
Dofetilide—Headache—Vinorelbine—hematologic cancer	0.000144	0.000377	CcSEcCtD
Dofetilide—Influenza—Doxorubicin—hematologic cancer	0.000144	0.000376	CcSEcCtD
Dofetilide—Asthenia—Ifosfamide—hematologic cancer	0.000143	0.000375	CcSEcCtD
Dofetilide—Oedema—Triamcinolone—hematologic cancer	0.000143	0.000374	CcSEcCtD
Dofetilide—Syncope—Dexamethasone—hematologic cancer	0.000143	0.000373	CcSEcCtD
Dofetilide—Syncope—Betamethasone—hematologic cancer	0.000143	0.000373	CcSEcCtD
Dofetilide—Arrhythmia—Prednisone—hematologic cancer	0.000142	0.000372	CcSEcCtD
Dofetilide—Sweating—Methotrexate—hematologic cancer	0.000142	0.000371	CcSEcCtD
Dofetilide—Paraesthesia—Etoposide—hematologic cancer	0.000142	0.00037	CcSEcCtD
Dofetilide—Shock—Triamcinolone—hematologic cancer	0.000141	0.000368	CcSEcCtD
Dofetilide—Insomnia—Prednisolone—hematologic cancer	0.000141	0.000368	CcSEcCtD
Dofetilide—Dyspnoea—Etoposide—hematologic cancer	0.000141	0.000368	CcSEcCtD
Dofetilide—Dizziness—Thalidomide—hematologic cancer	0.00014	0.000367	CcSEcCtD
Dofetilide—Angina pectoris—Doxorubicin—hematologic cancer	0.00014	0.000366	CcSEcCtD
Dofetilide—Nausea—Bortezomib—hematologic cancer	0.00014	0.000366	CcSEcCtD
Dofetilide—Loss of consciousness—Dexamethasone—hematologic cancer	0.00014	0.000366	CcSEcCtD
Dofetilide—Loss of consciousness—Betamethasone—hematologic cancer	0.00014	0.000366	CcSEcCtD
Dofetilide—Asthenia—Vincristine—hematologic cancer	0.00014	0.000365	CcSEcCtD
Dofetilide—Paraesthesia—Prednisolone—hematologic cancer	0.00014	0.000365	CcSEcCtD
Dofetilide—Diarrhoea—Carmustine—hematologic cancer	0.00014	0.000365	CcSEcCtD
Dofetilide—Nausea—Bleomycin—hematologic cancer	0.000139	0.000363	CcSEcCtD
Dofetilide—Rash—Thiotepa—hematologic cancer	0.000138	0.000362	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—MDM2—hematologic cancer	0.000138	0.00215	CbGpPWpGaD
Dofetilide—Dermatitis—Thiotepa—hematologic cancer	0.000138	0.000362	CcSEcCtD
Dofetilide—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000138	0.000362	CcSEcCtD
Dofetilide—Diarrhoea—Alitretinoin—hematologic cancer	0.000138	0.000361	CcSEcCtD
Dofetilide—Headache—Thiotepa—hematologic cancer	0.000138	0.00036	CcSEcCtD
Dofetilide—Hypertension—Betamethasone—hematologic cancer	0.000137	0.000359	CcSEcCtD
Dofetilide—Hypertension—Dexamethasone—hematologic cancer	0.000137	0.000359	CcSEcCtD
Dofetilide—Diarrhoea—Ifosfamide—hematologic cancer	0.000137	0.000357	CcSEcCtD
Dofetilide—Nausea—Vinorelbine—hematologic cancer	0.000137	0.000357	CcSEcCtD
Dofetilide—Asthenia—Irinotecan—hematologic cancer	0.000136	0.000356	CcSEcCtD
Dofetilide—Asthenia—Mitoxantrone—hematologic cancer	0.000136	0.000356	CcSEcCtD
Dofetilide—Anxiety—Dexamethasone—hematologic cancer	0.000135	0.000353	CcSEcCtD
Dofetilide—Anxiety—Betamethasone—hematologic cancer	0.000135	0.000353	CcSEcCtD
Dofetilide—Dizziness—Carmustine—hematologic cancer	0.000135	0.000353	CcSEcCtD
Dofetilide—Pain—Etoposide—hematologic cancer	0.000135	0.000353	CcSEcCtD
Dofetilide—Urinary tract infection—Epirubicin—hematologic cancer	0.000135	0.000352	CcSEcCtD
Dofetilide—Rash—Thalidomide—hematologic cancer	0.000134	0.00035	CcSEcCtD
Dofetilide—Dermatitis—Thalidomide—hematologic cancer	0.000134	0.00035	CcSEcCtD
Dofetilide—Dizziness—Alitretinoin—hematologic cancer	0.000134	0.000349	CcSEcCtD
Dofetilide—Diarrhoea—Vincristine—hematologic cancer	0.000133	0.000348	CcSEcCtD
Dofetilide—Headache—Thalidomide—hematologic cancer	0.000133	0.000348	CcSEcCtD
Dofetilide—Pain—Prednisolone—hematologic cancer	0.000133	0.000348	CcSEcCtD
Dofetilide—Sweating—Epirubicin—hematologic cancer	0.000133	0.000347	CcSEcCtD
Dofetilide—Asthenia—Gemcitabine—hematologic cancer	0.000133	0.000347	CcSEcCtD
Dofetilide—Dizziness—Ifosfamide—hematologic cancer	0.000132	0.000345	CcSEcCtD
Dofetilide—Nausea—Thiotepa—hematologic cancer	0.00013	0.000341	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.00013	0.000341	CcSEcCtD
Dofetilide—Oedema—Dexamethasone—hematologic cancer	0.00013	0.000339	CcSEcCtD
Dofetilide—Oedema—Betamethasone—hematologic cancer	0.00013	0.000339	CcSEcCtD
Dofetilide—Diarrhoea—Irinotecan—hematologic cancer	0.00013	0.000339	CcSEcCtD
Dofetilide—Diarrhoea—Mitoxantrone—hematologic cancer	0.00013	0.000339	CcSEcCtD
Dofetilide—Insomnia—Triamcinolone—hematologic cancer	0.000129	0.000338	CcSEcCtD
Dofetilide—Gastrointestinal pain—Etoposide—hematologic cancer	0.000129	0.000337	CcSEcCtD
Dofetilide—Dizziness—Vincristine—hematologic cancer	0.000129	0.000337	CcSEcCtD
Dofetilide—Rash—Carmustine—hematologic cancer	0.000129	0.000336	CcSEcCtD
Dofetilide—Dermatitis—Carmustine—hematologic cancer	0.000129	0.000336	CcSEcCtD
Dofetilide—Paraesthesia—Triamcinolone—hematologic cancer	0.000129	0.000336	CcSEcCtD
Dofetilide—Headache—Carmustine—hematologic cancer	0.000128	0.000334	CcSEcCtD
Dofetilide—Shock—Dexamethasone—hematologic cancer	0.000128	0.000334	CcSEcCtD
Dofetilide—Shock—Betamethasone—hematologic cancer	0.000128	0.000334	CcSEcCtD
Dofetilide—Dyspnoea—Triamcinolone—hematologic cancer	0.000128	0.000333	CcSEcCtD
Dofetilide—Rash—Alitretinoin—hematologic cancer	0.000127	0.000333	CcSEcCtD
Dofetilide—Dermatitis—Alitretinoin—hematologic cancer	0.000127	0.000333	CcSEcCtD
Dofetilide—Bradycardia—Epirubicin—hematologic cancer	0.000127	0.000331	CcSEcCtD
Dofetilide—Headache—Alitretinoin—hematologic cancer	0.000127	0.000331	CcSEcCtD
Dofetilide—Angioedema—Prednisone—hematologic cancer	0.000127	0.000331	CcSEcCtD
Dofetilide—Diarrhoea—Gemcitabine—hematologic cancer	0.000126	0.00033	CcSEcCtD
Dofetilide—Nausea—Thalidomide—hematologic cancer	0.000126	0.00033	CcSEcCtD
Dofetilide—Rash—Ifosfamide—hematologic cancer	0.000126	0.000329	CcSEcCtD
Dofetilide—Dermatitis—Ifosfamide—hematologic cancer	0.000126	0.000329	CcSEcCtD
Dofetilide—Hyperhidrosis—Betamethasone—hematologic cancer	0.000126	0.000328	CcSEcCtD
Dofetilide—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000126	0.000328	CcSEcCtD
Dofetilide—Dizziness—Irinotecan—hematologic cancer	0.000125	0.000328	CcSEcCtD
Dofetilide—Abdominal pain—Etoposide—hematologic cancer	0.000125	0.000326	CcSEcCtD
Dofetilide—Urinary tract infection—Doxorubicin—hematologic cancer	0.000125	0.000326	CcSEcCtD
Dofetilide—Syncope—Prednisone—hematologic cancer	0.000124	0.000325	CcSEcCtD
Dofetilide—Asthenia—Cisplatin—hematologic cancer	0.000124	0.000323	CcSEcCtD
Dofetilide—Sweating—Doxorubicin—hematologic cancer	0.000123	0.000322	CcSEcCtD
Dofetilide—Rash—Vincristine—hematologic cancer	0.000123	0.000321	CcSEcCtD
Dofetilide—Dermatitis—Vincristine—hematologic cancer	0.000123	0.000321	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000123	0.00191	CbGpPWpGaD
Dofetilide—Oedema peripheral—Epirubicin—hematologic cancer	0.000123	0.000321	CcSEcCtD
Dofetilide—Pain—Triamcinolone—hematologic cancer	0.000122	0.00032	CcSEcCtD
Dofetilide—Headache—Vincristine—hematologic cancer	0.000122	0.000319	CcSEcCtD
Dofetilide—Loss of consciousness—Prednisone—hematologic cancer	0.000122	0.000318	CcSEcCtD
Dofetilide—Nausea—Carmustine—hematologic cancer	0.000121	0.000317	CcSEcCtD
Dofetilide—Nausea—Alitretinoin—hematologic cancer	0.00012	0.000314	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—HRAS—hematologic cancer	0.00012	0.00186	CbGpPWpGaD
Dofetilide—Hypertension—Prednisone—hematologic cancer	0.00012	0.000313	CcSEcCtD
Dofetilide—Rash—Irinotecan—hematologic cancer	0.00012	0.000313	CcSEcCtD
Dofetilide—Rash—Mitoxantrone—hematologic cancer	0.00012	0.000313	CcSEcCtD
Dofetilide—Dermatitis—Mitoxantrone—hematologic cancer	0.000119	0.000312	CcSEcCtD
Dofetilide—Dermatitis—Irinotecan—hematologic cancer	0.000119	0.000312	CcSEcCtD
Dofetilide—Headache—Irinotecan—hematologic cancer	0.000119	0.000311	CcSEcCtD
Dofetilide—Headache—Mitoxantrone—hematologic cancer	0.000119	0.000311	CcSEcCtD
Dofetilide—Nausea—Ifosfamide—hematologic cancer	0.000119	0.00031	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000118	0.000309	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000118	0.000309	CcSEcCtD
Dofetilide—Arthralgia—Prednisone—hematologic cancer	0.000118	0.000308	CcSEcCtD
Dofetilide—Diarrhoea—Cisplatin—hematologic cancer	0.000118	0.000308	CcSEcCtD
Dofetilide—Anxiety—Prednisone—hematologic cancer	0.000118	0.000307	CcSEcCtD
Dofetilide—Insomnia—Dexamethasone—hematologic cancer	0.000117	0.000307	CcSEcCtD
Dofetilide—Insomnia—Betamethasone—hematologic cancer	0.000117	0.000307	CcSEcCtD
Dofetilide—Bradycardia—Doxorubicin—hematologic cancer	0.000117	0.000307	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.000117	0.00182	CbGpPWpGaD
Dofetilide—Paraesthesia—Betamethasone—hematologic cancer	0.000117	0.000305	CcSEcCtD
Dofetilide—Paraesthesia—Dexamethasone—hematologic cancer	0.000117	0.000305	CcSEcCtD
Dofetilide—Rash—Gemcitabine—hematologic cancer	0.000117	0.000305	CcSEcCtD
Dofetilide—Dermatitis—Gemcitabine—hematologic cancer	0.000116	0.000304	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	0.000116	0.0018	CbGpPWpGaD
Dofetilide—Headache—Gemcitabine—hematologic cancer	0.000116	0.000303	CcSEcCtD
Dofetilide—Nausea—Vincristine—hematologic cancer	0.000116	0.000302	CcSEcCtD
Dofetilide—Oedema peripheral—Doxorubicin—hematologic cancer	0.000113	0.000297	CcSEcCtD
Dofetilide—Asthenia—Etoposide—hematologic cancer	0.000113	0.000296	CcSEcCtD
Dofetilide—Oedema—Prednisone—hematologic cancer	0.000113	0.000296	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CREB1—hematologic cancer	0.000113	0.00175	CbGpPWpGaD
Dofetilide—Nausea—Irinotecan—hematologic cancer	0.000113	0.000295	CcSEcCtD
Dofetilide—Nausea—Mitoxantrone—hematologic cancer	0.000113	0.000295	CcSEcCtD
Dofetilide—Back pain—Methotrexate—hematologic cancer	0.000112	0.000293	CcSEcCtD
Dofetilide—Shock—Prednisone—hematologic cancer	0.000111	0.000291	CcSEcCtD
Dofetilide—Arrhythmia—Epirubicin—hematologic cancer	0.000111	0.000291	CcSEcCtD
Dofetilide—Pain—Dexamethasone—hematologic cancer	0.000111	0.00029	CcSEcCtD
Dofetilide—Pain—Betamethasone—hematologic cancer	0.000111	0.00029	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL6R—hematologic cancer	0.00011	0.00171	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	0.00011	0.00171	CbGpPWpGaD
Dofetilide—Nausea—Gemcitabine—hematologic cancer	0.00011	0.000287	CcSEcCtD
Dofetilide—Hyperhidrosis—Prednisone—hematologic cancer	0.000109	0.000286	CcSEcCtD
Dofetilide—Rash—Cisplatin—hematologic cancer	0.000109	0.000284	CcSEcCtD
Dofetilide—Dermatitis—Cisplatin—hematologic cancer	0.000108	0.000284	CcSEcCtD
Dofetilide—Diarrhoea—Etoposide—hematologic cancer	0.000108	0.000282	CcSEcCtD
Dofetilide—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000106	0.000278	CcSEcCtD
Dofetilide—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000106	0.000278	CcSEcCtD
Dofetilide—Back pain—Epirubicin—hematologic cancer	0.000105	0.000274	CcSEcCtD
Dofetilide—Dizziness—Etoposide—hematologic cancer	0.000104	0.000273	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000103	0.000269	CcSEcCtD
Dofetilide—Dizziness—Prednisolone—hematologic cancer	0.000103	0.000269	CcSEcCtD
Dofetilide—Arrhythmia—Doxorubicin—hematologic cancer	0.000103	0.000269	CcSEcCtD
Dofetilide—Asthenia—Triamcinolone—hematologic cancer	0.000103	0.000268	CcSEcCtD
Dofetilide—Abdominal pain—Dexamethasone—hematologic cancer	0.000103	0.000268	CcSEcCtD
Dofetilide—Abdominal pain—Betamethasone—hematologic cancer	0.000103	0.000268	CcSEcCtD
Dofetilide—Nausea—Cisplatin—hematologic cancer	0.000102	0.000267	CcSEcCtD
Dofetilide—Insomnia—Prednisone—hematologic cancer	0.000102	0.000267	CcSEcCtD
Dofetilide—Paraesthesia—Prednisone—hematologic cancer	0.000102	0.000265	CcSEcCtD
Dofetilide—Cough—Methotrexate—hematologic cancer	0.000101	0.000264	CcSEcCtD
Dofetilide—Rash—Etoposide—hematologic cancer	9.95e-05	0.00026	CcSEcCtD
Dofetilide—Dermatitis—Etoposide—hematologic cancer	9.94e-05	0.00026	CcSEcCtD
Dofetilide—Headache—Etoposide—hematologic cancer	9.88e-05	0.000258	CcSEcCtD
Dofetilide—Chest pain—Methotrexate—hematologic cancer	9.86e-05	0.000258	CcSEcCtD
Dofetilide—Arthralgia—Methotrexate—hematologic cancer	9.86e-05	0.000258	CcSEcCtD
Dofetilide—Rash—Prednisolone—hematologic cancer	9.81e-05	0.000256	CcSEcCtD
Dofetilide—Dermatitis—Prednisolone—hematologic cancer	9.8e-05	0.000256	CcSEcCtD
Dofetilide—Headache—Prednisolone—hematologic cancer	9.75e-05	0.000255	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	9.74e-05	0.00151	CbGpPWpGaD
Dofetilide—Syncope—Epirubicin—hematologic cancer	9.72e-05	0.000254	CcSEcCtD
Dofetilide—Back pain—Doxorubicin—hematologic cancer	9.7e-05	0.000254	CcSEcCtD
Dofetilide—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	9.61e-05	0.00149	CbGpPWpGaD
Dofetilide—Palpitations—Epirubicin—hematologic cancer	9.58e-05	0.00025	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—PRKCG—hematologic cancer	9.57e-05	0.00149	CbGpPWpGaD
Dofetilide—Loss of consciousness—Epirubicin—hematologic cancer	9.53e-05	0.000249	CcSEcCtD
Dofetilide—Dizziness—Triamcinolone—hematologic cancer	9.46e-05	0.000247	CcSEcCtD
Dofetilide—Cough—Epirubicin—hematologic cancer	9.46e-05	0.000247	CcSEcCtD
Dofetilide—Nausea—Etoposide—hematologic cancer	9.37e-05	0.000245	CcSEcCtD
Dofetilide—Hypertension—Epirubicin—hematologic cancer	9.36e-05	0.000245	CcSEcCtD
Dofetilide—Asthenia—Dexamethasone—hematologic cancer	9.32e-05	0.000244	CcSEcCtD
Dofetilide—Asthenia—Betamethasone—hematologic cancer	9.32e-05	0.000244	CcSEcCtD
Dofetilide—Gastrointestinal pain—Prednisone—hematologic cancer	9.25e-05	0.000242	CcSEcCtD
Dofetilide—Nausea—Prednisolone—hematologic cancer	9.24e-05	0.000242	CcSEcCtD
Dofetilide—Chest pain—Epirubicin—hematologic cancer	9.23e-05	0.000241	CcSEcCtD
Dofetilide—Arthralgia—Epirubicin—hematologic cancer	9.23e-05	0.000241	CcSEcCtD
Dofetilide—Anxiety—Epirubicin—hematologic cancer	9.19e-05	0.00024	CcSEcCtD
Dofetilide—Hyperhidrosis—Methotrexate—hematologic cancer	9.14e-05	0.000239	CcSEcCtD
Dofetilide—Rash—Triamcinolone—hematologic cancer	9.02e-05	0.000236	CcSEcCtD
Dofetilide—Dermatitis—Triamcinolone—hematologic cancer	9.02e-05	0.000236	CcSEcCtD
Dofetilide—Syncope—Doxorubicin—hematologic cancer	8.99e-05	0.000235	CcSEcCtD
Dofetilide—Headache—Triamcinolone—hematologic cancer	8.97e-05	0.000234	CcSEcCtD
Dofetilide—Abdominal pain—Prednisone—hematologic cancer	8.94e-05	0.000234	CcSEcCtD
Dofetilide—Diarrhoea—Betamethasone—hematologic cancer	8.88e-05	0.000232	CcSEcCtD
Dofetilide—Diarrhoea—Dexamethasone—hematologic cancer	8.88e-05	0.000232	CcSEcCtD
Dofetilide—Palpitations—Doxorubicin—hematologic cancer	8.86e-05	0.000232	CcSEcCtD
Dofetilide—Oedema—Epirubicin—hematologic cancer	8.84e-05	0.000231	CcSEcCtD
Dofetilide—Loss of consciousness—Doxorubicin—hematologic cancer	8.81e-05	0.00023	CcSEcCtD
Dofetilide—Cough—Doxorubicin—hematologic cancer	8.75e-05	0.000229	CcSEcCtD
Dofetilide—Shock—Epirubicin—hematologic cancer	8.7e-05	0.000227	CcSEcCtD
Dofetilide—Hypertension—Doxorubicin—hematologic cancer	8.66e-05	0.000226	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.61e-05	0.000225	CcSEcCtD
Dofetilide—Dizziness—Dexamethasone—hematologic cancer	8.59e-05	0.000224	CcSEcCtD
Dofetilide—Dizziness—Betamethasone—hematologic cancer	8.59e-05	0.000224	CcSEcCtD
Dofetilide—Hyperhidrosis—Epirubicin—hematologic cancer	8.55e-05	0.000223	CcSEcCtD
Dofetilide—Insomnia—Methotrexate—hematologic cancer	8.55e-05	0.000223	CcSEcCtD
Dofetilide—Chest pain—Doxorubicin—hematologic cancer	8.54e-05	0.000223	CcSEcCtD
Dofetilide—Arthralgia—Doxorubicin—hematologic cancer	8.54e-05	0.000223	CcSEcCtD
Dofetilide—Anxiety—Doxorubicin—hematologic cancer	8.51e-05	0.000222	CcSEcCtD
Dofetilide—Nausea—Triamcinolone—hematologic cancer	8.5e-05	0.000222	CcSEcCtD
Dofetilide—Paraesthesia—Methotrexate—hematologic cancer	8.49e-05	0.000222	CcSEcCtD
Dofetilide—Dyspnoea—Methotrexate—hematologic cancer	8.43e-05	0.00022	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL1B—hematologic cancer	8.37e-05	0.0013	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CASP3—hematologic cancer	8.35e-05	0.0013	CbGpPWpGaD
Dofetilide—Rash—Dexamethasone—hematologic cancer	8.19e-05	0.000214	CcSEcCtD
Dofetilide—Rash—Betamethasone—hematologic cancer	8.19e-05	0.000214	CcSEcCtD
Dofetilide—Oedema—Doxorubicin—hematologic cancer	8.18e-05	0.000214	CcSEcCtD
Dofetilide—Dermatitis—Dexamethasone—hematologic cancer	8.18e-05	0.000214	CcSEcCtD
Dofetilide—Dermatitis—Betamethasone—hematologic cancer	8.18e-05	0.000214	CcSEcCtD
Dofetilide—Headache—Dexamethasone—hematologic cancer	8.14e-05	0.000213	CcSEcCtD
Dofetilide—Headache—Betamethasone—hematologic cancer	8.14e-05	0.000213	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—JUN—hematologic cancer	8.11e-05	0.00126	CbGpPWpGaD
Dofetilide—Asthenia—Prednisone—hematologic cancer	8.11e-05	0.000212	CcSEcCtD
Dofetilide—Pain—Methotrexate—hematologic cancer	8.08e-05	0.000211	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.06e-05	0.000211	CcSEcCtD
Dofetilide—Shock—Doxorubicin—hematologic cancer	8.05e-05	0.00021	CcSEcCtD
Dofetilide—Insomnia—Epirubicin—hematologic cancer	8e-05	0.000209	CcSEcCtD
Dofetilide—Paraesthesia—Epirubicin—hematologic cancer	7.94e-05	0.000208	CcSEcCtD
Dofetilide—Hyperhidrosis—Doxorubicin—hematologic cancer	7.91e-05	0.000207	CcSEcCtD
Dofetilide—Dyspnoea—Epirubicin—hematologic cancer	7.89e-05	0.000206	CcSEcCtD
Dofetilide—Diarrhoea—Prednisone—hematologic cancer	7.74e-05	0.000202	CcSEcCtD
Dofetilide—Gastrointestinal pain—Methotrexate—hematologic cancer	7.73e-05	0.000202	CcSEcCtD
Dofetilide—Nausea—Dexamethasone—hematologic cancer	7.71e-05	0.000202	CcSEcCtD
Dofetilide—Nausea—Betamethasone—hematologic cancer	7.71e-05	0.000202	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—HRAS—hematologic cancer	7.6e-05	0.00118	CbGpPWpGaD
Dofetilide—Pain—Epirubicin—hematologic cancer	7.56e-05	0.000198	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—EP300—hematologic cancer	7.48e-05	0.00116	CbGpPWpGaD
Dofetilide—Dizziness—Prednisone—hematologic cancer	7.48e-05	0.000195	CcSEcCtD
Dofetilide—Abdominal pain—Methotrexate—hematologic cancer	7.47e-05	0.000195	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.46e-05	0.000195	CcSEcCtD
Dofetilide—Insomnia—Doxorubicin—hematologic cancer	7.4e-05	0.000193	CcSEcCtD
Dofetilide—Paraesthesia—Doxorubicin—hematologic cancer	7.35e-05	0.000192	CcSEcCtD
Dofetilide—Dyspnoea—Doxorubicin—hematologic cancer	7.3e-05	0.000191	CcSEcCtD
Dofetilide—Gastrointestinal pain—Epirubicin—hematologic cancer	7.23e-05	0.000189	CcSEcCtD
Dofetilide—Rash—Prednisone—hematologic cancer	7.13e-05	0.000186	CcSEcCtD
Dofetilide—Dermatitis—Prednisone—hematologic cancer	7.12e-05	0.000186	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	7.09e-05	0.0011	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CREB1—hematologic cancer	7.09e-05	0.0011	CbGpPWpGaD
Dofetilide—Headache—Prednisone—hematologic cancer	7.08e-05	0.000185	CcSEcCtD
Dofetilide—Pain—Doxorubicin—hematologic cancer	7e-05	0.000183	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—BRAF—hematologic cancer	7e-05	0.00109	CbGpPWpGaD
Dofetilide—Abdominal pain—Epirubicin—hematologic cancer	6.99e-05	0.000183	CcSEcCtD
Dofetilide—Asthenia—Methotrexate—hematologic cancer	6.78e-05	0.000177	CcSEcCtD
Dofetilide—Nausea—Prednisone—hematologic cancer	6.72e-05	0.000176	CcSEcCtD
Dofetilide—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.69e-05	0.000175	CcSEcCtD
Dofetilide—Abdominal pain—Doxorubicin—hematologic cancer	6.47e-05	0.000169	CcSEcCtD
Dofetilide—Diarrhoea—Methotrexate—hematologic cancer	6.47e-05	0.000169	CcSEcCtD
Dofetilide—Asthenia—Epirubicin—hematologic cancer	6.35e-05	0.000166	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	6.28e-05	0.000976	CbGpPWpGaD
Dofetilide—Dizziness—Methotrexate—hematologic cancer	6.25e-05	0.000163	CcSEcCtD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	6.19e-05	0.000962	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TNF—hematologic cancer	6.08e-05	0.000944	CbGpPWpGaD
Dofetilide—Diarrhoea—Epirubicin—hematologic cancer	6.05e-05	0.000158	CcSEcCtD
Dofetilide—Rash—Methotrexate—hematologic cancer	5.96e-05	0.000156	CcSEcCtD
Dofetilide—Dermatitis—Methotrexate—hematologic cancer	5.95e-05	0.000156	CcSEcCtD
Dofetilide—Headache—Methotrexate—hematologic cancer	5.92e-05	0.000155	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	5.9e-05	0.000917	CbGpPWpGaD
Dofetilide—Asthenia—Doxorubicin—hematologic cancer	5.87e-05	0.000153	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—MDM2—hematologic cancer	5.86e-05	0.000911	CbGpPWpGaD
Dofetilide—Dizziness—Epirubicin—hematologic cancer	5.85e-05	0.000153	CcSEcCtD
Dofetilide—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	5.82e-05	0.000905	CbGpPWpGaD
Dofetilide—Nausea—Methotrexate—hematologic cancer	5.61e-05	0.000147	CcSEcCtD
Dofetilide—Diarrhoea—Doxorubicin—hematologic cancer	5.6e-05	0.000146	CcSEcCtD
Dofetilide—Rash—Epirubicin—hematologic cancer	5.58e-05	0.000146	CcSEcCtD
Dofetilide—Dermatitis—Epirubicin—hematologic cancer	5.57e-05	0.000146	CcSEcCtD
Dofetilide—Headache—Epirubicin—hematologic cancer	5.54e-05	0.000145	CcSEcCtD
Dofetilide—Dizziness—Doxorubicin—hematologic cancer	5.41e-05	0.000141	CcSEcCtD
Dofetilide—Nausea—Epirubicin—hematologic cancer	5.25e-05	0.000137	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	5.21e-05	0.00081	CbGpPWpGaD
Dofetilide—Rash—Doxorubicin—hematologic cancer	5.16e-05	0.000135	CcSEcCtD
Dofetilide—Dermatitis—Doxorubicin—hematologic cancer	5.16e-05	0.000135	CcSEcCtD
Dofetilide—Headache—Doxorubicin—hematologic cancer	5.13e-05	0.000134	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—MTR—hematologic cancer	5.12e-05	0.000795	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL6—hematologic cancer	4.9e-05	0.000762	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	4.87e-05	0.000757	CbGpPWpGaD
Dofetilide—Nausea—Doxorubicin—hematologic cancer	4.86e-05	0.000127	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	3.37e-05	0.000524	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	3.33e-05	0.000517	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—HRAS—hematologic cancer	3.22e-05	0.0005	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	3.1e-05	0.000482	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	3.06e-05	0.000475	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FTCD—hematologic cancer	2.59e-05	0.000402	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GMPS—hematologic cancer	2.59e-05	0.000402	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PHYH—hematologic cancer	2.59e-05	0.000402	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.37e-05	0.000368	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DCK—hematologic cancer	2.07e-05	0.000321	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ASNS—hematologic cancer	2.07e-05	0.000321	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.07e-05	0.000321	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HDC—hematologic cancer	1.96e-05	0.000305	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CDA—hematologic cancer	1.79e-05	0.000279	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PC—hematologic cancer	1.73e-05	0.000268	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.67e-05	0.000259	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GBA—hematologic cancer	1.67e-05	0.000259	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTAP—hematologic cancer	1.52e-05	0.000237	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FHL2—hematologic cancer	1.36e-05	0.000211	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AGRN—hematologic cancer	1.33e-05	0.000207	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—IDH2—hematologic cancer	1.26e-05	0.000196	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMMR—hematologic cancer	1.26e-05	0.000196	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.19e-05	0.000185	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CA9—hematologic cancer	1.16e-05	0.00018	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ACP5—hematologic cancer	1.16e-05	0.00018	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.14e-05	0.000177	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—IDH1—hematologic cancer	1.09e-05	0.000169	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—TXN—hematologic cancer	1.07e-05	0.000167	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.07e-05	0.000167	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.07e-05	0.000167	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.05e-05	0.000163	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.01e-05	0.000157	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	9.82e-06	0.000153	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CRABP1—hematologic cancer	9.82e-06	0.000153	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALOX5—hematologic cancer	9.57e-06	0.000149	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NUP98—hematologic cancer	9.27e-06	0.000144	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ADCY7—hematologic cancer	9e-06	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOA3—hematologic cancer	9e-06	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NUP214—hematologic cancer	8.94e-06	0.000139	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTR—hematologic cancer	8.75e-06	0.000136	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCG2—hematologic cancer	8.75e-06	0.000136	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ENO2—hematologic cancer	8.58e-06	0.000133	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTT1—hematologic cancer	8.33e-06	0.000129	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SDC1—hematologic cancer	8.14e-06	0.000126	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CD44—hematologic cancer	6.92e-06	0.000108	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NQO1—hematologic cancer	6.92e-06	0.000108	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYCS—hematologic cancer	6.55e-06	0.000102	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.51e-06	0.000101	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.77e-06	8.97e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.46e-06	8.49e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.3e-06	8.24e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.3e-06	8.24e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.69e-06	7.28e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.94e-06	6.12e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.65e-06	5.67e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.46e-06	5.38e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALB—hematologic cancer	3.42e-06	5.31e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.27e-06	5.08e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.02e-06	4.69e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTEN—hematologic cancer	2.61e-06	4.05e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—EP300—hematologic cancer	2.49e-06	3.86e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.84e-06	2.86e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKT1—hematologic cancer	1.5e-06	2.34e-05	CbGpPWpGaD
